Cure Hepatitis C Act of 2025

Cure Hepatitis C Act of 2025, S 1941; The Ian Kalvinkas Pediatric Liver Cancer Early Detection and Screening Act, HR 5355

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599/H.R. 6394 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482/H.R. 4407 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act H.Res. 1264/S.Res. 709 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2026. H.R. 8163 - the Provider Reimbursement Stability Act H.R. 8261 - Chronic Care Management Improvement Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies H.R. 9257/S. 4754 - Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records

Client expense: $400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973 - Momnibus Act H.R. 8163 - the Provider Reimbursement Stability Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic

Client expense: $400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

S.4189 (INSULIN Act), H.R.1492, S.832 (EPIC Act); Medicare drug price negotiation improvement and expansion; Medicare drug price negotiation delay periods and exemptions; drug prices, S.2276, H.R.3269 (ETHIC Act), H.R.6485, S.43 Skinny Labels, Big Savings Act, patent abuse reform, Prescription Drug Access and Affordability Act, TrumpRx, Medicare drug price negotiation delay periods and eligibility , S.1941 Cure Hepatitis C Act , global health, PEPFAR funding, USAID funding, global access to medicines, S.1040 Drug Competition Enhancement Act S. 1095 Stop STALLING Act S. 1096 Preserve Access to Affordable Generics and Biosimilars Act, S.1941 Cure Hepatitis C Act ,

Client expense: $99,577 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R. 1, the One Big Beautiful Bill; Comments to FDA on "Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Compounding Animal Drugs From Bulk Drug Substances [Docket No. FDA-2025-N-0082]"; LHHS Report Language Request to Improve the Care and Treatment of Long-Term Care Residents with Neuropsychiatric Symptoms; Comments to OMB on "Re: Request for Information: Deregulation"; Comments to HHS/DOGE on government efficiency, fraud, waste and PBMs; Comments on "Executive Order 14297 of May 12, 2025 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients"; Comments to CDC on "RE: June 25-26 Advisory Committee on Immunization Practices Meeting"; H.R.5316, the Drug Shortage Compounding and Patient Access Act; H.R.5256, the 340B ACCESS Act; Comments to FDA on "RE: Docket No. FDA-2025-N-2589, Comments on the Risks and Benefits of Menopause Hormone Therapy"; H.Res. 805, Recognizing October 2025 as American Pharmacists Month in honor of the contribution of pharmacists to provide safe, accessible, affordable, and beneficial patient care services and products to all residents and protect the public health of our communities; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]; H.R. 6703, the Lower Health Care Premiums for All Americans Act; H.R.5133, the Patient's Right to Know Their Medication Act; H.R. 4409, the Fair Pharmacies for Federal Employees Act; S.3549/H.R.6837, the Fiduciary Accountability, Integrity and Reform (FAIR) Act; H.R.7148, the Consolidated Appropriations Act of 2026; Rural Health Transformation Program; Creation and Implementation of TrumpRx; Comments to FDA on RFI, "Re: Increasing Access to Nonprescription Drugs; Request for Information"; S.3822, Break up Big Medicine Act; Comments to FDA on RFT, "Re: [Docket No. FDA-2025-N-6743] - Scientific and Clinical Considerations for Testosterone Replacement Therapy (TRT) in Men with Hypogonadism"; Comments to DoL, HHS, and DoT regarding "Re: Transparency in Coverage Proposed Rule [CMS-9882-P]"; Pharmacy Shortage Areas in reference to USC-NCPA joint project Mapping Tool; H.R. 7895, the PBM Kickback Prohibition Act; Comments to FDA on their comment request "Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Medication Guides for Prescription Drug Products [FDA-2025-N-6869]"; H.R.6509/S.3794, the SAFE Drug Act; H.R.5316, the Drug Shortage Compounding Patient Access Act; H.R.8779/S.4509, the Patients Before Monopolies Act; S.3788/H.R.8269, the CLEAR LABELS Act; S.1941, the Cure Hepatitis C Act of 2025;

Client expense: $270,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program. Support measures to prevent pharmacy benefit managers and commercial insurers from imposing discriminatory reimbursement policies on 340B covered entities. Support codification of covered entities ability to use contract pharmacies. Support protections against manufacturer-imposed claims submission requirements. Issue: Oppose efforts to reduce the scope of the 340B Drug Pricing Program and transition 340B into a rebate model. Oppose efforts to impose additional reporting requirements on 340B hospitals. Oppose efforts to restrict the 340B patient definition. Oppose efforts to restrict hospital eligibility for the 340B program. Oppose shift in 340B program administration from HRSA to CMS. Oppose restructuring the 340B program from an upfront discount to a retrospective rebate. Issue: Support policies to ensure access to robust and comprehensive coverage. Oppose insurance plans that do not meet Affordable Care Act (ACA) requirements. Support an extension of the enhanced premium tax credits (EPTCs) provided by the American Rescue Plan Act, or other policies to reduce premium payments, maintain enrollment, and reduce the uncompensated care burden on academic health systems. Support affordable and increased access to state ACA marketplace exchanges. Support policies that lower enrollees private insurance costs. Issue: Support policies to improve maternal health outcomes through expanded Medicaid coverage, enhanced data collection, and improved access to behavioral health care during the perinatal period. Issue: Educate Congress and the administration on the medical education and training continuum, higher education accreditation, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency. Issue: Provide guidance on the implementation of the No Surprises Act (P.L.116-260). Issue: Educate Congress and the administration on the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support policies to strengthen the behavioral health workforce, promote the uptake of integrated behavioral health models, advance mental health research, and ensure access to coverage and care. Issue: Educate Congress about the financial challenges facing academic health systems, academic medical centers, and teaching hospitals, including reimbursement challenges, workforce challenges, inflation, and others. Issue: Educate Congress about the role of academic health systems, academic medical centers, teaching hospitals, medical schools, and their affiliated faculty physicians play in providing care to all communities, including rural and underserved populations. Issue: Support reauthorization of the Childrens Hospitals Graduate Medical Education (CHGME) program. Issue: Support reauthorization of the National Health Service Corps (NHSC) and Teaching Health Center Graduate Medical Education (THCGME). Issue: Urge full staffing and funding for health, public health, and research agencies. Issue: Educate Congress and the administration about medical education as it relates to nutrition, hunger, and health; reproductive health; substance use disorders; medication assisted treatment for opioid use disorders; health care for people with disabilities; menopause and womens health; and maternal health. Issue: Educate Congress on resident expectations related to clinical practice and oppose so-called physician service mandates. H.R.6468 - Rural Residency Planning and Development Act of 2025 Issue: Support codification of the Health Resources & Services Administration (HRSA) rural residency planning and development program. Issue: Support providing discretionary funds for rural teaching hospitals to expand their residency programs. Issue: Encourage changes to Health Resources & Services Administration (HRSA) financial aid programs as a result of Free Application for Federal Student Aid (FAFSA) updates. Issue: Educate Congress on the use of artificial intelligence (AI) in academic medicine. P.L.-119-75 Consolidated Appropriations Act, 2026H.R.929/S.266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Issue: Support ability of Health Resources & Services Administration (HRSA) to implement evidenced-based practices for preventing suicide and improving mental health and resiliency among health care professionals, and for training health care professionals in appropriate strategies to address substance use disorders. H.R.4262/S.4110 - Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VII health professions programs. H.R.3593/S.1874 - Title VIII Nursing Workforce Reauthorization Act of 2025 Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VIII nursing workforce development programs. H.R.5428 - Medical Student Education Authorization Act Issue: Support long-term authorization for the Title VII Medical Student Education program, which provides grants to public institutions of higher education to expand or support graduate education for physicians, focusing on institutions in states with the most severe primary care provider shortage. H.Res.745 - Expressing support for the designation of October 1 as National Latino and Latina Physician Day. Issue: Support the designation of October 1 as National Latino and Latina Physician Day. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversight regarding changes to pediatric vaccine schedule. Issue: Provide comments on the Make America Healthy Again strategy. S.1941 - Cure Hepatitis C Act of 2025 Issue: Support funding to expand access to rapid screening, treatment, and services to support hepatitis C elimination. P.L.119-60 - National Defense Authorization Act for Fiscal Year 2026 H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 S.1071 - National Defense Authorization Act for Fiscal Year 2026 Issue: Support robust medical staffing for the military health system and provisions that strengthen the military medical workforce. Issue: Oppose CDC website changes related to autism and vaccinations.

Client expense: $821,438 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Impacts of H.R. 1, One Big Beautiful Bill Act Support for Cure Hepatitis C Act of 2025, S. 1941 Concerns with delayed Notice of Funding Opportunity announcements at HHS, and specifically HRSA Implementation concerns with S.331 - HALT Fentanyl Act

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Cure Hepatitis C Act of 2025, S 1941; The Ian Kalvinkas Pediatric Liver Cancer Early Detection and Screening Act, HR 5355

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and policies related to: Physician/nurse practitioner reimbursement Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Creation of a Medicare graduate nursing education program Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Medicare and Medicaid policies related to telehealth services Medicaid eligibility expansion and state options Medicaid waiver application procedures Protection and improvement of Medicaid Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21), including the Rural Health Transformation Program Inclusion of nurse practitioners in the bonus program for clinicians practicing in primary care Health Professional Shortage Areas (HPSAs) H.R. 498, Do No Harm in Medicaid Act H.R. 1317/S. 575, Improving Care and Access to Nurses (I CAN) Act H.R. 1616/S. 1805, Promoting Access to Diabetic Shoes Act H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 2531/S. 1232, Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 2586, Reentry Act of 2025 H.R. 3108/S. 1535, Rural Patient Monitoring Access Act H.R. 3684, Save Americas Rural Hospitals Act H.R. 4231/S. 1973, Treat and Reduce Obesity Act H.R. 4619, Medicare Mental Health Inpatient Equity Act of 2025 H.R. 4773/S. 3350, ACO Assignment Improvement Act of 2025 H.R. 4849/S. 2556, Protecting Health Care and Lowering Costs Act H.R. 5081/S. 2709, Telehealth Modernization Act H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217, Rural Behavioral Health Improvement Act of 2025 H.R. 6199/S. 3934, Medical Nutrition Therapy Act of 2025 H.R. 7106, Enhancing Skilled Nursing Facilities Act H.R. 7787, Mental Health Workforce Act H.R. 7973, Momnibus Act S. 683/H.R. 7324, More Behavioral Health Providers Act S. 717/H.R. 6894, Increasing Access to Quality Cardiac Rehabilitation Care Act S. 1261/H.R. 4206, CONNECT for Health Act of 2025 S. 1816/H.R. 3514, Improving Seniors Timely Access to Care Act S. 1941, Cure Hepatitis C Act of 2025 S. 2954, Health Care Workforce Expansion Act of 2025

Client expense: Not reported · Firm income: $24,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act Chronic Care Management Improvement Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records

Client expense: $400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973 - Momnibus Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic

Client expense: $400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Impacts of H.R. 1, One Big Beautiful Bill Act Support for Cure Hepatitis C Act of 2025, S. 1941

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Cure Hepatitis C Act of 2025, S 1941; The Advisory Committee on Immunization Practices; THe Ian Kalvinkas Pediatric Liver Cancer Early Detection and Screening Act, HR 5355

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program. Support measures to prevent pharmacy benefit managers and commercial insurers from imposing discriminatory reimbursement policies on 340B covered entities. Support codification of covered entities ability to use contract pharmacies. Issue: Oppose efforts to reduce the scope of the 340B Drug Pricing Program and transition 340B into a rebate model. Oppose efforts to impose additional reporting requirements on 340B hospitals. Oppose efforts to restrict the 340B patient definition. Oppose efforts to restrict hospital eligibility for the 340B program. Oppose shift in 340B program administration from HRSA to CMS. Issue: Support policies to ensure access to robust and comprehensive coverage. Oppose insurance plans that do not meet Affordable Care Act (ACA) requirements. Support an extension of the enhanced premium tax credits (EPTCs) provided by the American Rescue Plan Act, or other policies to reduce premium payments, maintain enrollment, and reduce the uncompensated care burden on academic health systems. Issue: Support policies to improve maternal health outcomes through expanded Medicaid coverage, enhanced data collection, and improved access to behavioral health care during the perinatal period. Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency. Issue: Provide guidance on the implementation of the No Surprises Act (P.L.116-260). Issue: Educate Congress and the administration on the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support policies to strengthen the behavioral health workforce, promote the uptake of integrated behavioral health models, advance mental health research, and ensure access to coverage and care. Issue: Educate Congress about the financial challenges facing academic health systems, academic medical centers, and teaching hospitals, including reimbursement challenges, workforce challenges, inflation, and others. Issue: Educate Congress about the role of academic health systems, academic medical centers, teaching hospitals, medical schools, and their affiliated faculty physicians play in providing care to all communities, including rural and underserved populations. Issue: Support reauthorization of the Childrens Hospitals Graduate Medical Education (CHGME) program. Issue: Support reauthorization of the National Health Service Corps (NHSC) and Teaching Health Center Graduate Medical Education (THCGME). Issue: Urge full staffing and funding for health, public health, and research agencies. Issue: Educate Congress and the administration about medical education as it relates to nutrition, hunger, and health; reproductive health; substance use disorders; medication assisted treatment for opioid use disorders; health care for people with disabilities; menopause and womens health; and maternal health. Issue: Educate Congress on resident expectations related to clinical practice and oppose so-called physician service mandates. H.R.6468 - Rural Residency Planning and Development Act of 2025 Issue: Support codification of the Health Resources & Services Administration (HRSA) rural residency planning and development program. Issue: Support providing discretionary funds for rural teaching hospitals to expand their residency programs. Issue: Encourage changes to Health Resources & Services Administration (HRSA) financial aid programs as a result of Free Application for Federal Student Aid (FAFSA) updates. Issue: Educate Congress on the use of artificial intelligence (AI) in academic medicine. H.R.929/S.266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Issue: Support ability of Health Resources & Services Administration (HRSA) to implement evidenced-based practices for preventing suicide and improving mental health and resiliency among health care professionals, and for training health care professionals in appropriate strategies to address substance use disorders. H.R.4262/S.4110 - Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VII health professions programs. H.R.3593/S.1874 - Title VIII Nursing Workforce Reauthorization Act of 2025 Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VIII nursing workforce development programs. H.R.5428 - Medical Student Education Authorization Act Issue: Support long-term authorization for the Title VII Medical Student Education program, which provides grants to public institutions of higher education to expand or support graduate education for physicians, focusing on institutions in states with the most severe primary care provider shortage. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversight of leadership changes at the Centers for Disease Control & Prevention (CDC). Issue: Support oversight regarding changes to pediatric vaccine schedule. Issue: Provide comments on the Make America Healthy Again strategy. S.1941 - Cure Hepatitis C Act of 2025 Issue: Support funding to expand access to rapid screening, treatment, and services to support hepatitis C elimination. P.L.119-60 - National Defense Authorization Act for Fiscal Year 2026 H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 S.1071 - National Defense Authorization Act for Fiscal Year 2026 Issue: Support robust medical staffing for the military health system and provisions that strengthen the military medical workforce. Issue: Oppose CDC website changes related to autism and vaccinations.

Client expense: $577,720 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease

Client expense: Not reported · Firm income: $25,500

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Support for Medicaid programs at hospitals, including children's hospitals Impacts of H.R. 1, One Big Beautiful Bill Act Support for Cure Hepatitis C Act of 2025, S. 1941

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support Medicaid program and oppose cuts to benefits. Support reversal of cuts to Medicaid and the ACA in the OBBBA. Support bipartisan congressional oversight and investigation into the firing of CDC staff by the administration. Support S. 1941, the Cure Hepatitis C Act of 2025. Support the Protecting Free Vaccines Act. Support the Family Vaccine Protection Act. Support legislation to extend the enhanced ACE premium tax credits. Support H.R.6148, the Patients Over Paperwork Act of 2025.

Client expense: $21,832 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office

H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program. Support measures to prevent pharmacy benefit managers and commercial insurers from imposing discriminatory reimbursement policies on 340B covered entities. Support codification of covered entities ability to use contract pharmacies. Issue: Oppose efforts to reduce the scope of the 340B Drug Pricing Program and transition 340B into a rebate model. Oppose efforts to impose additional reporting requirements on 340B hospitals. Oppose efforts to restrict the 340B patient definition. Oppose efforts to restrict hospital eligibility for the 340B program. Issue: Oppose insurance plans that do not meet Affordable Care Act (ACA) requirements. Issue: Support policies to improve maternal health outcomes through expanded Medicaid coverage, enhanced data collection, and improved access to behavioral health care during the perinatal period. Issue: Educate Congress on development of laboratory developed tests (LDTs) at academic health systems and academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing Food & Drug Administration (FDA) regulation of the development of LDTs at academic health systems and academic medical centers. Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency. Issue: Provide guidance on the implementation of the No Surprises Act (P.L.116-260). Issue: Educate Congress and the administration on the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support policies to strengthen the behavioral health workforce, promote the uptake of integrated behavioral health models, advance mental health research, and ensure access to coverage and care. Issue: Educate Congress about the financial challenges facing academic health systems, academic medical centers, and teaching hospitals , including reimbursement challenges, workforce challenges, inflation, and others. Issue: Educate Congress about the role of academic health systems, academic medical centers, teaching hospitals, medical schools, and their affiliated faculty physicians play in providing care to all communities, including rural and underserved populations. Issue: Support reauthorization of the Childrens Hospitals Graduate Medical Education (CHGME) program. Issue: Support reauthorization of the National Health Service Corps (NHSC) and Teaching Health Center Graduate Medical Education (THCGME). Issue: Urge full staffing and funding for health, public health, and research agencies. Issue: Educate Congress and the administration about medical education as it relates to nutrition, hunger, and health; reproductive health; substance use disorders; medication assisted treatment for opioid use disorders; health care for people with disabilities; and maternal health. Issue: Educate Congress on resident expectations related to clinical practice and oppose so-called physician service mandates. H.R.6468 - Rural Residency Planning and Development Act of 2025 Issue: Support codification of the Health Resources & Services Administration (HRSA) rural residency planning and development program. Issue: Support providing discretionary funds for rural teaching hospitals to expand their residency programs. Issue: Encourage changes to Health Resources & Services Administration (HRSA) financial aid programs as a result of Free Application for Federal Student Aid (FAFSA) updates. Issue: Encourage the Department of Health & Human Services (HHS) to take actions to prevent further measles outbreaks. Issue: Educate Congress on the use of artificial intelligence (AI) in academic medicine. H.R.929/S.266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Issue: Support ability of Health Resources & Services Administration (HRSA) to implement evidenced-based practices for preventing suicide and improving mental health and resiliency among health care professionals, and for training health care professionals in appropriate strategies to address substance use disorders. H.R.4262 - Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VII health professions programs. H.R.3593/S.1874 - Title VIII Nursing Workforce Reauthorization Act of 2025 Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VIII nursing workforce development programs. H.R.5428 - Medical Student Education Authorization Act Issue: Support long-term authorization for the Title VII Medical Student Education program, which provides grants to public institutions of higher education to expand or support graduate education for physicians, focusing on institutions in states with the most severe primary care provider shortage. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversight of leadership changes at the Centers for Disease Control & Prevention (CDC). Issue: Provide comments on the Make America Healthy Again strategy. S.1941 - Cure Hepatitis C Act of 2025 Issue: Support funding to expand access to rapid screening, treatment, and services to support hepatitis C elimination. P.L.119-60 - National Defense Authorization Act for Fiscal Year 2026 H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 S.1071 - National Defense Authorization Act for Fiscal Year 2026 Issue: Support robust medical staffing for the military health system and provisions that strengthen the military medical workforce. Issue: Oppose CDC website changes related to autism and vaccinations.

Client expense: $708,395 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Cure Hepatitis C Act of 2025, S 1941; The Advisory Committee on Immunization Practices

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Rural Health Transformation Program included in One Big Beautiful Bill Act (H.R. 1) H.R. 4725/S. 2462 - Transparency, Readability, Understandability, Truth, and Helpfulness (TRUTH) in Labeling Act of 2025 S. 2532 - Safe Response Act S. 2540 - Comprehensive Addiction and Recovery Justice Grant Reauthorization Act of 2025 S. 1941 - Cure Hepatitis C Act of 2025 H.R. 4445 - Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025

Client expense: $46,531 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support the Medical Foods and Formulas Access Act (H.R. 5684) Support the Cure Hepatitis C Act (S. 1941) Support Colorados Medicaid State Plan Amendment to allow dispensing fees for the preparation and dispensing of parenteral nutrition as approved by the Colorado General Assembly and signed into law [SB 25-084].

Client expense: Not reported · Firm income: $25,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Support Medicaid program and oppose cuts to benefits. Oppose H.R. 21/S. 6, the Born Alive Abortion Survivors Protection Act. Protect the integrity of the United States Preventive Services Task Force. Support the Protecting Healthcare and Lowering Costs Act of 2025. Support reversal of cuts to Medicaid and the ACA in the OBBBA. Support bipartisan congressional oversight and investigation into the firing of CDC staff by the administration. Support S. 1941, the Cure Hepatitis C Act of 2025. Support the Protecting Free Vaccines Act. Support the Family Vaccine Protection Act.

Client expense: $24,052 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office

Support for Medicaid programs at hospitals, including children's hospitals Impacts of H.R. 1, One Big Beautiful Bill Act Support for Cure Hepatitis C Act of 2025, S. 1941

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program. Support measures to prevent pharmacy benefit managers and commercial insurers from imposing discriminatory reimbursement policies on 340B covered entities. Support codification of covered entities ability to use contract pharmacies. Issue: Oppose efforts to reduce the scope of the program and transition 340B into a rebate model. Oppose efforts to impose additional reporting requirements on 340B hospitals. Oppose efforts to restrict 340B patient definition. Oppose efforts to restrict hospital eligibility for the 340B program. Issue: Oppose insurance plans that do not meet Affordable Care Act (ACA) requirements. Issue: Support policies to improve maternal health outcomes through expanded Medicaid coverage, enhanced data collection, and improved access to behavioral health care during the perinatal period. Issue: Educate Congress on development of laboratory developed tests (LDTs) at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing Food & Drug Administration (FDA) regulation of the development of LDTs at academic medical centers. Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency. Issue: Provide guidance on the implementation of the No Surprises Act (P.L.116-260). Issue: Educate Congress and the administration on the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support policies to strengthen the behavioral health workforce, promote the uptake of integrated behavioral health models, advance mental health research, and ensure access to coverage and care. Issue: Educate Congress about the financial challenges facing academic medical centers, including reimbursement challenges, workforce challenges, inflation, and others. Issue: Educate Congress about the role of academic health systems, academic medical centers, teaching hospitals, medical schools, and their affiliated faculty physicians play in providing care to all communities, including rural and underserved populations. Issue: Support reauthorization of the Childrens Hospitals Graduate Medical Education (CHGME) program. Issue: Support reauthorization of the National Health Service Corps (NHSC) and Teaching Health Center Graduate Medical Education (THCGME). Issue: Urge full staffing and funding for health, public health, and research agencies. Issue: Educate Congress and the administration about medical education on nutrition, hunger, and health; reproductive health; substance use disorders; medication assisted treatment for opioid use disorders; health care for people with disabilities; and maternal health. Issue: Educate Congress on resident expectations related to clinical practice and oppose so-called physician service mandates. Issue: Support codification of Health Resources & Services Administrations (HRSA) rural residency planning and development program. Issue: Support providing discretionary funds for rural teaching hospitals to expand their residency programs. Issue: Encourage changes to Health Resources & Services Administration (HRSA) financial aid programs as a result of Free Application for Federal Student Aid (FAFSA) updates. Issue: Encourage the Department of Health & Human Services (HHS) to take actions to prevent further measles outbreaks. Issue: Educate Congress on the use of artificial intelligence (AI) in academic medicine. H.R.929/S.266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Issue: Support ability of Health Resources & Services Administration (HRSA) to implement evidenced-based practices for preventing suicide and improving mental health and resiliency among health care professionals, and for training health care professionals in appropriate strategies to address substance use disorders. H.R.4262 - Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VII health professions programs. H.R.3593/S.1874 - Title VIII Nursing Workforce Reauthorization Act of 2025 Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VIII nursing workforce development programs. H.R. 5428 - Medical Student Education Authorization Act Issue: Support long-term authorization for the Title VII Medical Student Education program, which provides grants to public institutions of higher education to expand or support graduate education for physicians, focusing on institutions in states with the most severe primary care provider shortage. S.331 - HALT Fentanyl Act Issue: Educate Congress on research and schedule I substances. Issue: Support the US Preventive Services Task Force. Issue: Support oversight of leadership changes at the Centers For Disease Control & Prevention (CDC). Issue: Provide comments on the Make America Healthy Again strategy. S.1941 - Cure Hepatitis C Act of 2025 Issue: Support funding to expand access to rapid screening, treatment, and services to support hepatitis C elimination.

Client expense: $758,175 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Cure Hepatitis C Act of 2025, S 1941; The Advisory Committee on Immunization Practices

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Sent letter in support of S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter in opposition of the Administration's broadening of its interpretation of a law that restricts many immigrants living in the United States from receiving federal public benefits. Joined coalition letter supporting a proposed FDA rule that would reduce nicotine levels in cigarettes and other combustible tobacco products. Joined a coalition letter supporting the bipartisan Resident Physician Shortage Reduction Act of 2025 (S. 2493 / H.R. 4731). The bill aims to expand the physician workforce by creating 2,000 new Medicare-supported GME positions annually over seven years, for a total of 14,000 new positions. A portion will be allocated to high-need areas. Submitted comment letter to CMS on its proposed 2026 Medicare Physician Fee Schedule. In its letter, ASAM outlined several suggestions to improve access to behavioral health services, including substance use disorder (SUD) treatment, and to better align treatment codes with this goal in mind. ASAM's recommendations focused on three key areas: outpatient SUD treatment, intensive outpatient treatment, and motivational interviewing. Joined coalition letter to Congressional leadership, supporting the extension of enhanced advance premium tax credits (APTCs). The credits have made health coverage more affordable for the over 24 million people who purchased plans through the Health Insurance Marketplaces. Advocated with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Endorsed the Michelle Alyssa Go Act that would increase the number of federal Medicaid-eligible in-patient/residential beds for individuals who are seeking treatment for mental health and substance use disorders.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Sent letter in support of S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter in opposition of the Administration's broadening of its interpretation of a law that restricts many immigrants living in the United States from receiving federal public benefits. Joined coalition letter supporting a proposed FDA rule that would reduce nicotine levels in cigarettes and other combustible tobacco products. Joined a coalition letter supporting the bipartisan Resident Physician Shortage Reduction Act of 2025 (S. 2493 / H.R. 4731). The bill aims to expand the physician workforce by creating 2,000 new Medicare-supported GME positions annually over seven years, for a total of 14,000 new positions. A portion will be allocated to high-need areas. Submitted comment letter to CMS on its proposed 2026 Medicare Physician Fee Schedule. In its letter, ASAM outlined several suggestions to improve access to behavioral health services, including substance use disorder (SUD) treatment, and to better align treatment codes with this goal in mind. ASAM's recommendations focused on three key areas: outpatient SUD treatment, intensive outpatient treatment, and motivational interviewing. Joined coalition letter to Congressional leadership, supporting the extension of enhanced advance premium tax credits (APTCs). The credits have made health coverage more affordable for the over 24 million people who purchased plans through the Health Insurance Marketplaces. Advocated with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Endorsed the Michelle Alyssa Go Act that would increase the number of federal Medicaid-eligible in-patient/residential beds for individuals who are seeking treatment for mental health and substance use disorders.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Sent letter in support of S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter in opposition of the Administration's broadening of its interpretation of a law that restricts many immigrants living in the United States from receiving federal public benefits. Joined coalition letter supporting a proposed FDA rule that would reduce nicotine levels in cigarettes and other combustible tobacco products. Joined a coalition letter supporting the bipartisan Resident Physician Shortage Reduction Act of 2025 (S. 2493 / H.R. 4731). The bill aims to expand the physician workforce by creating 2,000 new Medicare-supported GME positions annually over seven years, for a total of 14,000 new positions. A portion will be allocated to high-need areas. Submitted comment letter to CMS on its proposed 2026 Medicare Physician Fee Schedule. In its letter, ASAM outlined several suggestions to improve access to behavioral health services, including substance use disorder (SUD) treatment, and to better align treatment codes with this goal in mind. ASAM's recommendations focused on three key areas: outpatient SUD treatment, intensive outpatient treatment, and motivational interviewing. Joined coalition letter to Congressional leadership, supporting the extension of enhanced advance premium tax credits (APTCs). The credits have made health coverage more affordable for the over 24 million people who purchased plans through the Health Insurance Marketplaces. Advocated with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Endorsed the Michelle Alyssa Go Act that would increase the number of federal Medicaid-eligible in-patient/residential beds for individuals who are seeking treatment for mental health and substance use disorders.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Sent letter in support of S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter in opposition of the Administration's broadening of its interpretation of a law that restricts many immigrants living in the United States from receiving federal public benefits. Joined coalition letter supporting a proposed FDA rule that would reduce nicotine levels in cigarettes and other combustible tobacco products. Joined a coalition letter supporting the bipartisan Resident Physician Shortage Reduction Act of 2025 (S. 2493 / H.R. 4731). The bill aims to expand the physician workforce by creating 2,000 new Medicare-supported GME positions annually over seven years, for a total of 14,000 new positions. A portion will be allocated to high-need areas. Submitted comment letter to CMS on its proposed 2026 Medicare Physician Fee Schedule. In its letter, ASAM outlined several suggestions to improve access to behavioral health services, including substance use disorder (SUD) treatment, and to better align treatment codes with this goal in mind. ASAM's recommendations focused on three key areas: outpatient SUD treatment, intensive outpatient treatment, and motivational interviewing. Joined coalition letter to Congressional leadership, supporting the extension of enhanced advance premium tax credits (APTCs). The credits have made health coverage more affordable for the over 24 million people who purchased plans through the Health Insurance Marketplaces. Advocated with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Endorsed the Michelle Alyssa Go Act that would increase the number of federal Medicaid-eligible in-patient/residential beds for individuals who are seeking treatment for mental health and substance use disorders.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Sent letter in support of S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter in opposition of the Administration's broadening of its interpretation of a law that restricts many immigrants living in the United States from receiving federal public benefits. Joined coalition letter supporting a proposed FDA rule that would reduce nicotine levels in cigarettes and other combustible tobacco products. Joined a coalition letter supporting the bipartisan Resident Physician Shortage Reduction Act of 2025 (S. 2493 / H.R. 4731). The bill aims to expand the physician workforce by creating 2,000 new Medicare-supported GME positions annually over seven years, for a total of 14,000 new positions. A portion will be allocated to high-need areas. Submitted comment letter to CMS on its proposed 2026 Medicare Physician Fee Schedule. In its letter, ASAM outlined several suggestions to improve access to behavioral health services, including substance use disorder (SUD) treatment, and to better align treatment codes with this goal in mind. ASAM's recommendations focused on three key areas: outpatient SUD treatment, intensive outpatient treatment, and motivational interviewing. Joined coalition letter to Congressional leadership, supporting the extension of enhanced advance premium tax credits (APTCs). The credits have made health coverage more affordable for the over 24 million people who purchased plans through the Health Insurance Marketplaces. Advocated with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Endorsed the Michelle Alyssa Go Act that would increase the number of federal Medicaid-eligible in-patient/residential beds for individuals who are seeking treatment for mental health and substance use disorders.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Sent letter in support of S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter in opposition of the Administration's broadening of its interpretation of a law that restricts many immigrants living in the United States from receiving federal public benefits. Joined coalition letter supporting a proposed FDA rule that would reduce nicotine levels in cigarettes and other combustible tobacco products. Joined a coalition letter supporting the bipartisan Resident Physician Shortage Reduction Act of 2025 (S. 2493 / H.R. 4731). The bill aims to expand the physician workforce by creating 2,000 new Medicare-supported GME positions annually over seven years, for a total of 14,000 new positions. A portion will be allocated to high-need areas. Submitted comment letter to CMS on its proposed 2026 Medicare Physician Fee Schedule. In its letter, ASAM outlined several suggestions to improve access to behavioral health services, including substance use disorder (SUD) treatment, and to better align treatment codes with this goal in mind. ASAM's recommendations focused on three key areas: outpatient SUD treatment, intensive outpatient treatment, and motivational interviewing. Joined coalition letter to Congressional leadership, supporting the extension of enhanced advance premium tax credits (APTCs). The credits have made health coverage more affordable for the over 24 million people who purchased plans through the Health Insurance Marketplaces. Advocated with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Endorsed the Michelle Alyssa Go Act that would increase the number of federal Medicaid-eligible in-patient/residential beds for individuals who are seeking treatment for mental health and substance use disorders.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773 - ACO Assignment Improvement Act of 2025 Medical Nutrition Therapy Act H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683 - More Behavioral Health Providers Act Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261 - CONNECT for Health Act H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act H.R. 1227/S. 475: the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173: Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206: Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482: National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232: Workplace Violence Prevention for Health Care and Social Service Workers Act Hospice certification and recertification Immunization policies Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records

Client expense: $380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773 - ACO Assignment Improvement Act of 2025 Medical Nutrition Therapy Act H.R. 2509/S. 931- Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683 - More Behavioral Health Providers Act S. 1261 - CONNECT for Health Act H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act H.R. 1227/S. 475: the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232: Workplace Violence Prevention for Health Care and Social Service Workers Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic

Client expense: $380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

CDC Funding in FY 2026 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, injury and violence prevention, public health preparedness, epi and lab capacity, Data Modernization, Center for Forecasting Outbreak and Analytics, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases, and chronic diseases; Regulation of Tobacco/Nicotine and flavors; Increase access to substance use treatment; Preserve Prevention and Public Health Funding; Training for overdose response and code enforcement when responding to PH threats; Cure Hepatitis C Act (S. 1941); Restoring SNAP cuts; Insurance coverage for vaccines; Public health workforce.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Cure Hepatitis C Act of 2025, S 1941; The Advisory Committee on Immunization Practices

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Joined coalition letters/sent letters to/lobbied Congress, urging them to protect Medicaid for individuals with mental health conditions and substance use disorders, in connection with the One Big Beautiful Bill Act. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Sent a letter to DOJ regarding amending DEA regulations to allow qualified practitioners to prescribe methadone for OUD for pharmacy administration/dispensing. Sent a letter to OMB, advocating for the streamlining of regulations that hinder innovation in public health and safety approaches that could meaningfully impact access to addiction treatment, including: (1) streamlining regulations to increase access to addiction treatment medications; and (2) reducing prescribing barriers that disincentivize clinicians from prescribing addiction treatment medications. Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Participated in Congressional briefing on the financial sustainability of addiction treatment services. In coalition with the Mental Health Liaison Group, joined a letter urging members of the House Energy & Commerce Committee to pass the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) out of committee. Sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. that outlined three top priorities for the agency's consideration, each of which would have a positive impact on the lives of Americans impacted by addiction. Joined coalition letters to House and Senate leadership urging them to reject the administration's elimination of the CDC's Office on Smoking and Health (OSH) and to continue funding CDC projects focused on reducing tobacco use. Joined a coalition letter about certain workforce reductions at HHS, including FDA and CDC, will hurt the country's ability to regulate harmful tobacco products and reduce tobacco use; the letter was to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. Joined a coalition letter to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. expressing concern over the recent decision to terminate the entire membership of the Advisory Committee on Immunization Practices (ACIP) within the Centers for Disease Control and Prevention (CDC). In response to ONDCPs request for input, sent a letter with recommendations to remove barriers to substance use disorder (SUD) treatment. Sent a letter to US Senators Bill Cassidy (LA) and Chris Van Hollen (MD), expressing strong support for S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment.

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Joined coalition letters/sent letters to/lobbied Congress, urging them to protect Medicaid for individuals with mental health conditions and substance use disorders, in connection with the One Big Beautiful Bill Act. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Sent a letter to DOJ regarding amending DEA regulations to allow qualified practitioners to prescribe methadone for OUD for pharmacy administration/dispensing. Sent a letter to OMB, advocating for the streamlining of regulations that hinder innovation in public health and safety approaches that could meaningfully impact access to addiction treatment, including: (1) streamlining regulations to increase access to addiction treatment medications; and (2) reducing prescribing barriers that disincentivize clinicians from prescribing addiction treatment medications. Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Participated in Congressional briefing on the financial sustainability of addiction treatment services. In coalition with the Mental Health Liaison Group, joined a letter urging members of the House Energy & Commerce Committee to pass the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) out of committee. Sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. that outlined three top priorities for the agency's consideration, each of which would have a positive impact on the lives of Americans impacted by addiction. Joined coalition letters to House and Senate leadership urging them to reject the administration's elimination of the CDC's Office on Smoking and Health (OSH) and to continue funding CDC projects focused on reducing tobacco use. Joined a coalition letter about certain workforce reductions at HHS, including FDA and CDC, will hurt the country's ability to regulate harmful tobacco products and reduce tobacco use; the letter was to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. Joined a coalition letter to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. expressing concern over the recent decision to terminate the entire membership of the Advisory Committee on Immunization Practices (ACIP) within the Centers for Disease Control and Prevention (CDC). In response to ONDCPs request for input, sent a letter with recommendations to remove barriers to substance use disorder (SUD) treatment. Sent a letter to US Senators Bill Cassidy (LA) and Chris Van Hollen (MD), expressing strong support for S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment.

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Joined coalition letters/sent letters to/lobbied Congress, urging them to protect Medicaid for individuals with mental health conditions and substance use disorders, in connection with the One Big Beautiful Bill Act. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Sent a letter to DOJ regarding amending DEA regulations to allow qualified practitioners to prescribe methadone for OUD for pharmacy administration/dispensing. Sent a letter to OMB, advocating for the streamlining of regulations that hinder innovation in public health and safety approaches that could meaningfully impact access to addiction treatment, including: (1) streamlining regulations to increase access to addiction treatment medications; and (2) reducing prescribing barriers that disincentivize clinicians from prescribing addiction treatment medications. Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Participated in Congressional briefing on the financial sustainability of addiction treatment services. In coalition with the Mental Health Liaison Group, joined a letter urging members of the House Energy & Commerce Committee to pass the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) out of committee. Sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. that outlined three top priorities for the agency's consideration, each of which would have a positive impact on the lives of Americans impacted by addiction. Joined coalition letters to House and Senate leadership urging them to reject the administration's elimination of the CDC's Office on Smoking and Health (OSH) and to continue funding CDC projects focused on reducing tobacco use. Joined a coalition letter about certain workforce reductions at HHS, including FDA and CDC, will hurt the country's ability to regulate harmful tobacco products and reduce tobacco use; the letter was to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. Joined a coalition letter to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. expressing concern over the recent decision to terminate the entire membership of the Advisory Committee on Immunization Practices (ACIP) within the Centers for Disease Control and Prevention (CDC). In response to ONDCPs request for input, sent a letter with recommendations to remove barriers to substance use disorder (SUD) treatment. Sent a letter to US Senators Bill Cassidy (LA) and Chris Van Hollen (MD), expressing strong support for S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment.

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Joined coalition letters/sent letters to/lobbied Congress, urging them to protect Medicaid for individuals with mental health conditions and substance use disorders, in connection with the One Big Beautiful Bill Act. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Sent a letter to DOJ regarding amending DEA regulations to allow qualified practitioners to prescribe methadone for OUD for pharmacy administration/dispensing. Sent a letter to OMB, advocating for the streamlining of regulations that hinder innovation in public health and safety approaches that could meaningfully impact access to addiction treatment, including: (1) streamlining regulations to increase access to addiction treatment medications; and (2) reducing prescribing barriers that disincentivize clinicians from prescribing addiction treatment medications. Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Participated in Congressional briefing on the financial sustainability of addiction treatment services. In coalition with the Mental Health Liaison Group, joined a letter urging members of the House Energy & Commerce Committee to pass the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) out of committee. Sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. that outlined three top priorities for the agency's consideration, each of which would have a positive impact on the lives of Americans impacted by addiction. Joined coalition letters to House and Senate leadership urging them to reject the administration's elimination of the CDC's Office on Smoking and Health (OSH) and to continue funding CDC projects focused on reducing tobacco use. Joined a coalition letter about certain workforce reductions at HHS, including FDA and CDC, will hurt the country's ability to regulate harmful tobacco products and reduce tobacco use; the letter was to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. Joined a coalition letter to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. expressing concern over the recent decision to terminate the entire membership of the Advisory Committee on Immunization Practices (ACIP) within the Centers for Disease Control and Prevention (CDC). In response to ONDCPs request for input, sent a letter with recommendations to remove barriers to substance use disorder (SUD) treatment. Sent a letter to US Senators Bill Cassidy (LA) and Chris Van Hollen (MD), expressing strong support for S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment.

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Joined coalition letters/sent letters to/lobbied Congress, urging them to protect Medicaid for individuals with mental health conditions and substance use disorders, in connection with the One Big Beautiful Bill Act. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Sent a letter to DOJ regarding amending DEA regulations to allow qualified practitioners to prescribe methadone for OUD for pharmacy administration/dispensing. Sent a letter to OMB, advocating for the streamlining of regulations that hinder innovation in public health and safety approaches that could meaningfully impact access to addiction treatment, including: (1) streamlining regulations to increase access to addiction treatment medications; and (2) reducing prescribing barriers that disincentivize clinicians from prescribing addiction treatment medications. Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Participated in Congressional briefing on the financial sustainability of addiction treatment services. In coalition with the Mental Health Liaison Group, joined a letter urging members of the House Energy & Commerce Committee to pass the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) out of committee. Sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. that outlined three top priorities for the agency's consideration, each of which would have a positive impact on the lives of Americans impacted by addiction. Joined coalition letters to House and Senate leadership urging them to reject the administration's elimination of the CDC's Office on Smoking and Health (OSH) and to continue funding CDC projects focused on reducing tobacco use. Joined a coalition letter about certain workforce reductions at HHS, including FDA and CDC, will hurt the country's ability to regulate harmful tobacco products and reduce tobacco use; the letter was to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. Joined a coalition letter to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. expressing concern over the recent decision to terminate the entire membership of the Advisory Committee on Immunization Practices (ACIP) within the Centers for Disease Control and Prevention (CDC). In response to ONDCPs request for input, sent a letter with recommendations to remove barriers to substance use disorder (SUD) treatment. Sent a letter to US Senators Bill Cassidy (LA) and Chris Van Hollen (MD), expressing strong support for S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment.

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Joined coalition letters/sent letters to/lobbied Congress, urging them to protect Medicaid for individuals with mental health conditions and substance use disorders, in connection with the One Big Beautiful Bill Act. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Sent a letter to DOJ regarding amending DEA regulations to allow qualified practitioners to prescribe methadone for OUD for pharmacy administration/dispensing. Sent a letter to OMB, advocating for the streamlining of regulations that hinder innovation in public health and safety approaches that could meaningfully impact access to addiction treatment, including: (1) streamlining regulations to increase access to addiction treatment medications; and (2) reducing prescribing barriers that disincentivize clinicians from prescribing addiction treatment medications. Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Participated in Congressional briefing on the financial sustainability of addiction treatment services. In coalition with the Mental Health Liaison Group, joined a letter urging members of the House Energy & Commerce Committee to pass the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) out of committee. Sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. that outlined three top priorities for the agency's consideration, each of which would have a positive impact on the lives of Americans impacted by addiction. Joined coalition letters to House and Senate leadership urging them to reject the administration's elimination of the CDC's Office on Smoking and Health (OSH) and to continue funding CDC projects focused on reducing tobacco use. Joined a coalition letter about certain workforce reductions at HHS, including FDA and CDC, will hurt the country's ability to regulate harmful tobacco products and reduce tobacco use; the letter was to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. Joined a coalition letter to US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. expressing concern over the recent decision to terminate the entire membership of the Advisory Committee on Immunization Practices (ACIP) within the Centers for Disease Control and Prevention (CDC). In response to ONDCPs request for input, sent a letter with recommendations to remove barriers to substance use disorder (SUD) treatment. Sent a letter to US Senators Bill Cassidy (LA) and Chris Van Hollen (MD), expressing strong support for S. 1941- the Cure Hepatitis C Act of 2025, which aims to establish an innovative purchasing model and support a public health infrastructure for a test-to-treat hepatitis C virus (HCV) program, thereby improving patient access to comprehensive treatment.

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)